D. E. Shaw & Co., Inc.
- SEC CIK
- 0001009207
- Latest filing
- Aug 14, 2026
AGRX holding history
Agile Therapeutics Inc in every 13F filed by D. E. Shaw & Co., Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
AGRX overviewAll 13F holders of AGRXFull Q2 2026 holdings
- Shares (Q2 2022)
- 0
- Sold out in Q2 2022
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 5
- Since Q1 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2022 | 0 | $0 | 0.0% | −54,933−100.0% | Sold outConverted for a 1-for-40 split | Holders |
| Q1 2022 | 2,197,334 | $460.0K | <0.1% | +36,328+1.7% | Added | Holders |
| Q4 2021 | 2,161,006 | $1.05M | <0.1% | +1,839,143+571.4% | Added | Holders |
| Q3 2021 | 321,863 | $310.0K | <0.1% | +227,201+240.0% | Added | Holders |
| Q2 2021 | 94,662 | $126.0K | <0.1% | −7,269−7.1% | Reduced | Holders |
| Q1 2021 | 101,931 | $212.0K | <0.1% | – | – | Holders |
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.